Intraoperative radiation therapy for high-risk pediatric neuroblastoma (Q41742757)

8 October 2017

title

Intraoperative radiation therapy for high-risk pediatric neuroblastoma (English)

1 reference

intraoperative radiation therapy

8 October 2017

main subject

1 reference

Matthay KK

1 reference

8 October 2017

Haas-Kogan DA

1 reference

8 October 2017

Fisch BM

1 reference

8 October 2017

Wara WM

1 reference

8 October 2017

Swift PS

1 reference

8 October 2017

Farmer DL

1 reference

8 October 2017

Harrison MR

1 reference

8 October 2017

Albanese C

1 reference

8 October 2017

Weinberg V

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

International Journal of Radiation Oncology Biology Physics

8 October 2017

published in

1 reference

8 October 2017

1 reference

8 October 2017

1 reference

8 October 2017

page(s)

985-992

1 reference

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The surgical challenge of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Myeloablative combination chemotherapy without total body irradiation for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Second primary tumors following radiotherapy for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Lessons from our children.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Intraoperative radiotherapy: the Japanese experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The usefulness of intraoperative radiation therapy in the treatment of pelvic recurrence of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Intraoperative radiation therapy: cut bait or keep on fishing?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Locally advanced rectal carcinoma: Pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Clinical evaluation of intraoperative radiotherapy for carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Electron beam intraoperative radiation therapy for pediatric neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Intraoperative radiotherapy in the treatment of neuroblastoma: report of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Intra-operative radiation therapy in pediatric neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

High-dose rate intraoperative radiation therapy for pediatric solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Feasibility of intraoperative electron beam radiation therapy in the treatment of locally advanced pediatric malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The Mobetron: A New Concept for IORT

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The effect of complete excision on stage III neuroblastoma: a report of the European Neuroblastoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "debulking" treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Improvement in survival after excision of primary tumor in stage III neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Evaluation of the role of surgery in 130 patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The role of surgery in localized neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

The role of surgery in the management of stage IV neuroblastoma: a single institution study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

An evaluation of the role of surgery in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Renal cell carcinoma after therapy for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

Long-term results of therapy for stage C neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900432-6

7 January 2021

10.1016/S0360-3016(00)00432-6

Identifiers

DOI

1 reference

8 October 2017

1 reference